Chester County News and Community Website
WASHINGTON, D.C. — The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration (FDA) approved the first generic version of liraglutide injection, …
FDA Approves First Generic Liraglutide Injection, Ushering in a New Era for Type 2 Diabetes Treatment Read More
WASHINGTON, D.C. — The fight against obstructive sleep apnea (OSA) has taken a monumental leap forward. For the first time, the U.S. Food and Drug Administration (FDA) has approved a drug …
FDA Approves Zepbound in Landmark Move to Battle Obstructive Sleep Apnea Read More
WASHINGTON, D.C. — A seismic shift in pediatric medical care has arrived with the FDA’s approval of Ryoncil (remestemcel-L-rknd), a revolutionary therapy aimed at tackling the devastating condition known as steroid-refractory …
FDA Approves Groundbreaking Cell Therapy for Life-Threatening Pediatric Disease Read More
WASHINGTON, D.C. — A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially approved Symvess, the first acellular tissue-engineered vessel designed to repair damaged …
FDA Approves First-Ever Tissue-Engineered Vessel for Vascular Trauma Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS) has launched an ambitious and hard-hitting initiative designed to counteract misinformation and empower parents with the truth about childhood …
HHS Declares War on Misinformation with the Groundbreaking ‘Let’s Get Real’ Campaign Read More
WASHINGTON, D.C. — A chilling milestone in U.S. public health has been confirmed. The Centers for Disease Control and Prevention (CDC) recently announced the nation’s first severe case of avian …
First Severe Case of H5N1 Bird Flu in U.S. Sparks Urgent Reminder for Precautions Read More
MALVERN, PA — Endo, Inc. (OTCQX: NDOI) has introduced a new tool to support men dealing with Peyronie’s disease (PD). The self-assessment screening app, designed to help individuals identify and …
ICYMI: New App Helps Men Address Peyronie’s Disease Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the Data and Safety Monitoring Board (DSMB) has cleared the continuation of its Phase 1/2 OCU410 ArMaDa clinical trial. This trial is …
Ocugen’s Gene Therapy Trial for Dry AMD Advances Read More
WEST CHESTER, PA — Recognizing that “whole family” participation in addiction treatment can lead to better outcomes for people struggling with substance use disorders, ETHOS Treatment LLC – with six …
ETHOS Launches Family Program for Those with Loved Ones in Recovery Read More
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) has unveiled significant preclinical results for its proprietary Ac-EBTATE radiopharmaceutical, demonstrating remarkable efficacy against somatostatin receptor-2-positive neuroendocrine tumors (NETs), including small …
Promising New Radiopharmaceutical Shows Breakthrough Potential in Cancer Treatment Read More